Patrick M. Moriarty, MD, said in a video interview that he was very intrigued by the results, and “not personally surprised.” They should stimulate interest in cardiologists to start measuring Lp(a) in their patients like those in this study, in whom the disease severity doesn’t match up with the clinical risk factors, said Dr. Moriarty of the University of Kansas, Kansas City.
Dr. Khan’s study was funded by the UK National Institute for Health Research. She reported having no financial conflicts of interest.